Industry Dissatisfied With Senate-Approved Pediatric Device Provisions
This article was originally published in The Gray Sheet
Executive Summary
Device industry lobbyists are seeking changes to provisions in the Senate user fee reauthorization bill relating to medical devices for children
You may also be interested in...
Industry Seeks Reforms To FDA Humanitarian Device Exemption Program
AdvaMed is calling for legislative and regulatory reforms to the rare-disease-focused humanitarian device exemption FDA approval pathway
Industry Seeks Reforms To FDA Humanitarian Device Exemption Program
AdvaMed is calling for legislative and regulatory reforms to the rare-disease-focused humanitarian device exemption FDA approval pathway
Gottlieb: Democratic White House Would Impact FDA Device Policy
A switch from Republican to Democratic control of the White House in 2008 could have tangible, near-term policy implications for FDA device and diagnostic oversight and postmarket study requirements, according to a former deputy commissioner with FDA